Cargando…

A key genomic subtype associated with lymphovascular invasion in invasive breast cancer

BACKGROUND: Lymphovascular invasion (LVI) is associated with the development of metastasis in invasive breast cancer (BC). However, the complex molecular mechanisms of LVI, which overlap with other oncogenic pathways, remain unclear. This study, using available large transcriptomic datasets, aims to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurozumi, Sasagu, Joseph, Chitra, Sonbul, Sultan, Alsaeed, Sami, Kariri, Yousif, Aljohani, Abrar, Raafat, Sara, Alsaleem, Mansour, Ogden, Angela, Johnston, Simon J, Aleskandarany, Mohammed A, Fujii, Takaaki, Shirabe, Ken, Caldas, Carlos, Ashankyty, Ibraheem, Dalton, Leslie, Ellis, Ian O, Desmedt, Christine, Green, Andrew R, Mongan, Nigel P, Rakha, Emad A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738092/ https://www.ncbi.nlm.nih.gov/pubmed/31114020 http://dx.doi.org/10.1038/s41416-019-0486-6

Ejemplares similares

Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer
por: Kariri, Yousif A., et al.
Publicado: (2019)

The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer
por: Kariri, Yousif A., et al.
Publicado: (2020)

The ITIM-Containing Receptor: Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) Modulates Immune Response and Confers Poor Prognosis in Invasive Breast Carcinoma
por: Joseph, Chitra, et al.
Publicado: (2020)

Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer
por: Joseph, Chitra, et al.
Publicado: (2019)

Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast Cancer
por: Kariri, Yousif A., et al.
Publicado: (2022)

Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer
por: Kariri, Yousif, et al.
Publicado: (2022)

Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer
por: Aljohani, Abrar I., et al.
Publicado: (2020)

The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development
por: Aljohani, Abrar I., et al.
Publicado: (2022)

The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer
por: Aljohani, Abrar I., et al.
Publicado: (2019)

Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancer
por: Aleskandarany, Mohammed A, et al.
Publicado: (2017)

Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival
por: Joseph, Chitra, et al.
Publicado: (2020)

Clinicopathological utility of human epidermal growth factor receptor 2 (HER2)-heterogeneity for next-generation treatments of triple-negative breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2021)

Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections
por: Muftah, Abir A., et al.
Publicado: (2017)

Chemokine (C‐C motif) receptor 7 (CCR7) associates with the tumour immune microenvironment but not progression in invasive breast carcinoma
por: Sonbul, Sultan N, et al.
Publicado: (2017)

Updates on Lymphovascular Invasion in Breast Cancer
por: Kuhn, Elisabetta, et al.
Publicado: (2023)

Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2022)

Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes
por: Joseph, Chitra, et al.
Publicado: (2018)

The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes
por: Althobiti, Maryam, et al.
Publicado: (2020)

Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair
por: Johnston, Simon J., et al.
Publicado: (2018)

Significance of lymphovascular space invasion in epithelial ovarian cancer
por: Matsuo, Koji, et al.
Publicado: (2012)

Lymphovascular Space Invasion in Robotic Surgery for Endometrial Cancer
por: Hopkins, Mark R., et al.
Publicado: (2014)

ERG Immunohistochemistry as an Endothelial Marker for Assessing Lymphovascular Invasion
por: Kim, Sehun, et al.
Publicado: (2013)

Prediction of lymphovascular space invasion in patients with endometrial cancer
por: Kim, Sang Il, et al.
Publicado: (2021)

Primary testicular carcinoid tumor with marked lymphovascular invasion
por: Lee, Hyun Jung, et al.
Publicado: (2021)

Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets
por: Kurozumi, Sasagu, et al.
Publicado: (2020)

Lymphovascular invasion and histologic grade are associated with specific genomic profiles in invasive carcinomas of the breast
por: Fidalgo, Felipe, et al.
Publicado: (2014)

An evaluation of lymphovascular invasion in relation to biology and prognosis according to subtypes in invasive breast cancer
por: Nishimura, Reiki, et al.
Publicado: (2022)

MRI-Based Radiomics for Preoperative Prediction of Lymphovascular Invasion in Patients With Invasive Breast Cancer
por: Nijiati, Mayidili, et al.
Publicado: (2022)

The complementary role of lymphovascular invasion and perineural invasion in the TNM staging process of rectal cancer
por: Chen, Tong, et al.
Publicado: (2022)

Prognostic Significance of Lymphovascular Space Invasion in Epithelial Ovarian Cancer
por: Chen, Ming, et al.
Publicado: (2015)

Expression of cyclooxygenase-2 in cervical cancer is associated with lymphovascular invasion
por: Hoellen, Friederike, et al.
Publicado: (2016)

Lymphovascular invasion in testicular germ cell tumors: clinicopathological correlates
por: Yossepowitch, Ofer, et al.
Publicado: (2013)

CT volumetry for gastric adenocarcinoma: association with lymphovascular invasion and T-stages
por: Chen, Xiao-Li, et al.
Publicado: (2017)

Value of digital mammography in predicting lymphovascular invasion of breast cancer
por: Liu, Zhuangsheng, et al.
Publicado: (2020)

Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancer
por: Peters, Elke E M, et al.
Publicado: (2019)

Lymphovascular invasion of malignant melanoma presenting as gray streaks on dermoscopy
por: Yi, Lauren G., et al.
Publicado: (2020)

Oncological and prognostic impact of lymphovascular invasion in Colorectal Cancer patients
por: Wang, Xiaofei, et al.
Publicado: (2021)

The Potential of Artificial Intelligence to Detect Lymphovascular Invasion in Testicular Cancer
por: Ghosh, Abhisek, et al.
Publicado: (2021)

Evaluation of Lymphovascular Invasion by CD31 Expression in Gastric Adenocarcinoma
por: Miratashi Yazdi, Seyed Amir, et al.
Publicado: (2023)

Tumor volume and lymphovascular space invasion as a prognostic factor in early invasive adenocarcinoma of the cervix
por: Murakami, Isao, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_klc8k9tai8vi9247ndr59sk16n